Press Releases

Investor Alerts

Nov 12, 2019

Satsuma Pharmaceuticals Reports Third Quarter 2019 Financial and Business Results

Completed upsized initial public offering of $90.8 million in gross proceeds
Sep 17, 2019

Satsuma Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
Sep 12, 2019

Satsuma Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering of Common Stock
Sep 3, 2019

Satsuma Pharmaceuticals Announces Poster Presentations at the International Headache Congress
Sep 3, 2019

Satsuma Pharmaceuticals, Inc. Announces Proposed Initial Public Offering of Common Stock

Show per page